S. Matsumoto

发表

Identification of a lung adenocarcinoma cell line with CCDC6‐RET fusion gene and the effect of RET inhibitors in vitro and in vivo

Yutaka Suzuki, T. Kohno, T. Shibata, 2013, Cancer science.

Gastric metastasis by primary lung adenocarcinoma.

E. Shimizu, S. Matsumoto, A. Yamasaki, 2010, World journal of gastrointestinal oncology.

Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing tyrosine kinase inhibitors in small cell lung cancer cells: implication of c-Src and its inhibitor.

E. Shimizu, S. Matsumoto, T. Igishi, 2009, International journal of oncology.

Distinguishing Closely Related Pancreatic Cancer Subtypes In Vivo by 13C Glucose MRI without Hyperpolarization

James B. Mitchell, Albert P. Chen, P. Choyke, 2019, bioRxiv.

Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302

Shingo Matsumoto, Katarzyna A Rejniak, James B. Mitchell, 2015, Cancer & metabolism.

Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice

Shingo Matsumoto, Hellmut Merkle, Galen Reed, 2019, eLife.

Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1‐13C]pyruvate and 13C magnetic resonance spectroscopic imaging

James B. Mitchell, James B. Mitchell, H. D. Morris, 2011, Magnetic resonance in medicine.

Absolute oxygen tension (pO2) in murine fatty and muscle tissue as determined by EPR

Shingo Matsumoto, James B. Mitchell, Murali C Krishna, 2005, Magnetic resonance in medicine.

Accelerated 4D quantitative single point EPR imaging using model‐based reconstruction

A. McMillan, J. Zhuo, S. Matsumoto, 2015, Magnetic resonance in medicine.

Pollen augments the influence of desert dust on symptoms of adult asthma patients.

M. Nakamoto, E. Shimizu, S. Matsumoto, 2011, Allergology international : official journal of the Japanese Society of Allergology.

Synthesis of [1‐13C‐5‐12C]‐alpha‐ketoglutarate enables noninvasive detection of 2‐hydroxyglutarate

K. Camphausen, Natsuko Miura, J. Brender, 2021, NMR in biomedicine.

Evaluation of variant frequency in SARS-CoV-2 infection-related genes utilizing lung cancer genomic database

S. Matsumoto, K. Yoh, K. Goto, 2020, Lung Cancer.

Hyperpolarized 13C Magnetic Resonance Imaging as a Tool for Imaging Tissue Redox State, Oxidative Stress, Inflammation, and Cellular Metabolism

S. Matsumoto, N. J. Stewart, H. Hirata, 2021, Antioxidants & redox signaling.

Biomedical Applications of the Dynamic Nuclear Polarization and Parahydrogen Induced Polarization Techniques for Hyperpolarized 13C MR Imaging

S. Matsumoto, N. J. Stewart, N. Stewart, 2019, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.

Suppression of phosphatidylinositol 3-kinase/Akt signaling pathway is a determinant of the sensitivity to a novel histone deacetylase inhibitor, FK228, in lung adenocarcinoma cells.

E. Shimizu, S. Matsumoto, H. Nakanishi, 2005, Oncology reports.

Title Biochemical Features of a Catalytic Antibody Light Chain

S. Matsumoto, N. Kobayashi, Naoko Fujimoto, 2018 .

Biochemical Features of a Catalytic Antibody Light Chain, 22F6, Prepared from Human Lymphocytes*

S. Matsumoto, N. Kobayashi, Naoko Fujimoto, 2013, The Journal of Biological Chemistry.

UFT Plus Vinorelbine in Advanced Non-small Cell Lung Cancer: A Phase I and an Elderly Patient-Directed Phase II Study

E. Shimizu, S. Matsumoto, T. Igishi, 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Pulsed EPR imaging of nitroxides in mice.

Shingo Matsumoto, James B. Mitchell, Murali C Krishna, 2009, Journal of magnetic resonance.

Impact of the Characteristic Impedance of Coaxial Lines on the Sensitivity of a 750-MHz Electronically Tunable EPR Resonator

S. Matsumoto, H. Hirata, D. A. Komarov, 2018 .

Cancer esearch rated Systems and Technologies-Field Magnetic Resonance Imaging to Visualize Chronic R Cycling Hypoxia in Tumor-Bearing Mice

James B. Mitchell, S. Matsumoto, M. Krishna, 2010 .

Low-field magnetic resonance imaging to visualize chronic and cycling hypoxia in tumor-bearing mice.

James B. Mitchell, S. Matsumoto, M. Krishna, 2010, Cancer research.

Confirmation of Superoxide Generation via Xanthine Oxidase in Streptozotocin-induced Diabetic Mice

S. Matsumoto, H. Utsumi, H. Nawata, 2003, Free radical research.

Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity.

S. Matsumoto, H. Utsumi, H. Nawata, 2004, Free radical biology & medicine.

Longitudinal Imaging Studies of Tumor Microenvironment in Mice Treated with the mTOR Inhibitor Rapamycin

James B. Mitchell, S. Matsumoto, J. Gutkind, 2012, PloS one.

Simultaneous T2* mapping of 14N- and 15N-labeled dicarboxy-PROXYLs using CW-EPR-based single-point imaging.

S. Matsumoto, I. Kirilyuk, N. J. Stewart, 2019, Journal of magnetic resonance.

Multiplex gene‐panel testing for lung cancer patients

S. Toyooka, S. Ikeda, Y. Yatabe, 2020, Pathology international.

A phase I/II study of osimertinib in EGFR exon 20 insertion mutation-positive non-small cell lung cancer.

S. Matsumoto, K. Goto, S. Yano, 2021, Lung cancer.

Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab

S. Matsumoto, K. Goto, K. Kunimasa, 2020, Investigational New Drugs.

Activation of the AKT and STAT3 pathways and prolonged survival by a mutant EGFR in human lung cancer cells.

J. Yokota, S. Matsumoto, H. Akça, 2006, Lung cancer.

In Vivo Extracellular pH Mapping of Tumors Using Electron Paramagnetic Resonance.

S. Matsumoto, O. Inanami, I. Kirilyuk, 2018, Analytical chemistry.

Feasibility of in vivo three-dimensional T2* mapping using dicarboxy-PROXYL and CW-EPR-based single-point imaging

Shingo Matsumoto, Hiroshi Hirata, Osamu Inanami, 2017, Magnetic Resonance Materials in Physics, Biology and Medicine.

Echo-based Single Point Imaging (ESPI): a novel pulsed EPR imaging modality for high spatial resolution and quantitative oximetry.

James B. Mitchell, S. Matsumoto, M. Krishna, 2012, Journal of magnetic resonance.

Antibody Internalization into Living Cells via Crosslinker-mediated Endocytosis

A. Kishimura, S. Matsumoto, Y. Yamaguchi, 2015 .

Factors influencing the concordance of histological subtype diagnosis from biopsy and resected specimens of lung adenocarcinoma.

M. Tsuboi, H. Ohmatsu, M. Kojima, 2016, Lung cancer.

Influence of Asian Desert Dust on Lower Respiratory Tract Symptoms in Patients with Asthma over 4 Years

M. Nakamoto, E. Shimizu, S. Matsumoto, 2012, Yonago acta medica.

Correlation between Asian Dust Storms Worsening Asthma in Western Japan.

M. Nakamoto, E. Shimizu, S. Matsumoto, 2011, Allergology international : official journal of the Japanese Society of Allergology.

Docetaxel for platinum-refractory advanced thymic carcinoma.

H. Ohmatsu, S. Matsumoto, K. Yoh, 2015, Japanese journal of clinical oncology.

Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer

M. Tsuboi, S. Matsumoto, K. Yoh, 2017, Medicine.

Prognostic Factor Analysis in Patients With Small-Cell Lung Cancer Treated With Third-Line Chemotherapy.

H. Ohmatsu, Y. Ohe, S. Nomura, 2016, Clinical lung cancer.

Imatinib mesylate (STI571) enhances amrubicin-induced cytotoxic activity through inhibition of the phosphatidylinositol 3-kinase/Akt pathway in small cell lung cancer cells.

E. Shimizu, S. Matsumoto, T. Igishi, 2009, Oncology reports.

Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study

P. Paik, S. Matsumoto, Hiroshi Tanaka, 2021, Japanese journal of clinical oncology.

Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy

M. Tsuboi, H. Ohmatsu, A. Ochiai, 2015, Journal of Cancer Research and Clinical Oncology.

Quantitative imaging of pO2 in orthotopic murine gliomas: hypoxia correlates with resistance to radiation

James B. Mitchell, K. Camphausen, S. Matsumoto, 2017, Free radical research.

High proportion of tumor necrosis predicts poor survival in surgically resected high-grade neuroendocrine carcinoma of the lung.

M. Tsuboi, S. Matsumoto, K. Yoh, 2021, Lung cancer.

K-ras and rho A mutations in malignant pleural effusion.

M. Nakamoto, E. Shimizu, S. Matsumoto, 2001, International journal of oncology.

Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study

M. Satouchi, S. Matsumoto, K. Yoh, 2020, Trials.

Successful treatment with afatinib after grade 3 hepatotoxicity induced by both gefitinib and erlotinib in EGFR mutation-positive non-small cell lung cancer.

H. Ohmatsu, S. Matsumoto, K. Yoh, 2016, Lung cancer.

METex14 Skipping Testing Guidance for Lung Cancer Patients: The Guidance from the Biomarker Committee, the Japan Lung Cancer Society

S. Toyooka, S. Ikeda, Y. Yatabe, 2021, Haigan.

MET amplification results in heterogeneous responses to osimertinib in EGFR‐mutant lung cancer treated with erlotinib

S. Matsumoto, K. Goto, M. Sasaki, 2020, Cancer science.

Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine kinase inhibitor of EGFR and HER2, in patients with solid tumours.

R. Plummer, E. Frenkel, S. Matsumoto, 2015, European journal of cancer.

Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice.

James B. Mitchell, R. Gillies, S. Matsumoto, 2018, Cancer research.

A secondary RET mutation in the activation loop conferring resistance to vandetanib

T. Kohno, Y. Okuno, K. Tsumoto, 2018, Nature Communications.

Pyruvate Induces Transient Tumor Hypoxia by Enhancing Mitochondrial Oxygen Consumption and Potentiates the Anti-Tumor Effect of a Hypoxia-Activated Prodrug TH-302

Robert J. Gillies, Shingo Matsumoto, Masayuki Matsuo, 2014, PloS one.

Whole genome comparison of allelic imbalance between noninvasive and invasive small-sized lung adenocarcinomas.

Shingo Matsumoto, Eiji Shimizu, Koji Tsuta, 2009, Cancer research.

Association of Serum Anti-GAD Antibody and HLA Haplotypes with Type 1 Diabetes Mellitus Triggered by Nivolumab in Patients with Non-Small Cell Lung Cancer.

S. Matsumoto, K. Yoh, K. Goto, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Fatty acid amide hydrolase is a key regulator of the endocannabinoid‐induced myocardial tissue injury

B. Cravatt, S. Matsumoto, P. Pacher, 2011, Free radical biology & medicine.

Efficacy of Cell-Free and Concentrated Ascites Reinfusion Therapy for Palliative Care in a Patient with Malignant Pleural Mesothelioma: A Case Report.

H. Ohmatsu, S. Matsumoto, K. Yoh, 2017, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

Effect of amifostine, a radiation-protecting drug, on oxygen concentration in tissue measured by EPR oximetry and imaging

James B. Mitchell, S. Matsumoto, I. Nakanishi, 2017, Journal of clinical biochemistry and nutrition.

Magnetic resonance imaging of organic contrast agents in mice: capturing the whole-body redox landscape.

James B. Mitchell, M. Bernardo, S. Matsumoto, 2011, Free radical biology & medicine.

Correlation between Asian dust storms and worsening asthma in Western Japan.

M. Nakamoto, E. Shimizu, S. Matsumoto, 2011, Allergology international : official journal of the Japanese Society of Allergology.

Long-range heteronuclear J-coupling constants in esters: Implications for 13C metabolic MRI by side-arm parahydrogen-induced polarization.

S. Matsumoto, H. Kumeta, N. J. Stewart, 2018, Journal of magnetic resonance.

Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and

A. Veves, D. Wink, S. Matsumoto, 2010 .

Nationwide genomic screening network for the development of novel targeted therapies in advanced non-small cell lung cancer (LC-SCRUM-Japan).

T. Kohno, Y. Ohe, M. Satouchi, 2015 .

ERK activation and subsequent RB phosphorylation are important determinants of the sensitivity to paclitaxel in lung adenocarcinoma cells.

E. Shimizu, S. Matsumoto, H. Nakanishi, 2004, International journal of oncology.

EPR‐based oximetric imaging: a combination of single point‐based spatial encoding and T1 weighting

S. Matsumoto, M. Krishna, S. Kishimoto, 2018, Magnetic resonance in medicine.

Intracellular hypoxia of tumor tissue estimated by noninvasive electron paramagnetic resonance oximetry technique using paramagnetic probes.

James B. Mitchell, S. Matsumoto, M. Krishna, 2011, Biological & pharmaceutical bulletin.

Imatinib mesylate ( STI 571 ) enhances amrubicin-induced cytotoxic activity through inhibition of the phosphatidylinositol 3-kinase / Akt pathway in small cell lung cancer cells

E. Shimizu, S. Matsumoto, T. Igishi, 2022 .

The relationship between tissue oxygenation and redox status using magnetic resonance imaging

James B. Mitchell, S. Matsumoto, M. Krishna, 2012, International journal of oncology.

Prediction of Cancer Treatment Response by Physiologic and Metabolic Imaging.

S. Matsumoto, 2016, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

Are free radical reactions increased in the diabetic eye?

S. Matsumoto, H. Utsumi, Toshiaki Watanabe, 2006, Antioxidants & redox signaling.

In vivo measurement of redox status in streptozotocin-induced diabetic rat using targeted nitroxyl probes.

S. Matsumoto, H. Utsumi, Ken‐ichi Yamada, 2004, Antioxidants & redox signaling.

Low-field paramagnetic resonance imaging of tumor oxygenation and glycolytic activity in mice.

Shingo Matsumoto, James B. Mitchell, Murali C Krishna, 2008, The Journal of clinical investigation.

Protonation-induced Conformational Changes of 2-(N,N-Dimethylamino)ethanethiol. Importance of Strong N–H+···S and N–H+···S− Hydrogen Bonding

M. Aida, S. Matsumoto, H. Matsuura, 2003 .

Comparison of the efficiency of endobronchial ultrasound-guided transbronchial needle aspiration using a 22G needle versus 25G needle for the diagnosis of lymph node metastasis in patients with lung cancer: a prospective randomized, crossover study

S. Nomura, S. Matsumoto, K. Yoh, 2021, Translational lung cancer research.

Diagnostic and prognostic impact of serum‐soluble UL16‐binding protein 2 in lung cancer patients

M. Nakamoto, E. Shimizu, S. Matsumoto, 2012, Cancer science.

Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study.

H. Ohmatsu, Y. Ohe, S. Matsumoto, 2014, Japanese journal of clinical oncology.

In vivo measurement of tissue oxygen using electron paramagnetic resonance spectroscopy with oxygen-sensitive paramagnetic particle, lithium phthalocyanine.

S. Matsumoto, M. Krishna, F. Hyodo, 2010, Methods in molecular biology.

A novel method of preparing the monoform structure of catalytic antibody light chain

S. Matsumoto, Y. Katayama, R. Kato, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Sequential treatment with SN-38 followed by 5-fluorouracil shows synergistic cytotoxic activity in small cell lung cancer cells.

E. Shimizu, S. Matsumoto, T. Igishi, 2008, Oncology reports.

Synthesis of Nitroxyl Radicals for Overhauser‐enhanced Magnetic Resonance Imaging

S. Matsumoto, H. Utsumi, K. Sakai, 2008, Archiv der Pharmazie.

Enhancement of nitroxide‐reducing activity in rats after chronic administration of vitamin E, vitamin C, and idebenone examined by an in Vivo electron spin resonance technique

S. Matsumoto, Yijing Lin, N. Tsuchihashi, 1998, Magnetic resonance in medicine.

Improvement strategies for successful next-generation sequencing analysis of lung cancer.

S. Matsumoto, K. Goto, K. Kunimasa, 2020, Future oncology.

Biochemical features and antiviral activity of a monomeric catalytic antibody light‐chain 23D4 against influenza A virus

S. Matsumoto, Y. Katayama, Tatsuhiro Yamamoto, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Targeting ABL1-mediated oxidative stress adaptation in fumarate hydratase-deficient cancer.

James B. Mitchell, W. Linehan, R. Srinivasan, 2014, Cancer cell.

Simultaneous molecular imaging of redox reactions monitored by Overhauser-enhanced MRI with 14N- and 15N-labeled nitroxyl radicals

Shingo Matsumoto, Hideo Utsumi, Ken-ichi Yamada, 2006, Proceedings of the National Academy of Sciences of the United States of America.

Procedes de preparation d'acide azetidine-2-carboxylique et d'intermediaires de cet acide

S. Matsumoto, Kenji Inoue, H. Awaji, 1998 .

Hyperpolarized 13C Magnetic Resonance Imaging of Fumarate Metabolism by Parahydrogen‐induced Polarization: A Proof‐of‐Concept in vivo Study

S. Matsumoto, N. J. Stewart, H. Hirata, 2021, Chemphyschem : a European journal of chemical physics and physical chemistry.

Structural, optical, and photophysical properties of nickel(II) alkylthioporphyrins: insights from experimental and DFT/TDDFT studies.

E. Baerends, S. Matsumoto, A. Rosa, 2005, Inorganic Chemistry.

Synthesis and evaluation of 13C‐labeled 5‐5‐dimethyl‐1‐pyrroline‐N‐oxide aimed at in vivo detection of reactive oxygen species using hyperpolarized 13C‐MRI

James B. Mitchell, J. Brender, S. Matsumoto, 2019, Free radical biology & medicine.

EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3‐bromopyruvate

Shingo Matsumoto, Hellmut Merkle, Murali C Krishna, 2013, Magnetic resonance in medicine.

Tandem reductive amination and Michael addition. Synthesis of optically active pyrrolidine nucleus

S. Matsumoto, M. Inaba, S. Saitô, 1986 .

Tandem Reductive Amination and Michael Addition. Synthesis of Optically Active Pyrrolidine Nucleus.

S. Matsumoto, M. Inaba, S. Saitô, 1987 .

Quantum chemical calculations and vibrational analysis of compounds containing carbon–phosphorus multiple and single bonds

S. Matsumoto, H. Matsuura, K. Ohno, 2003 .

Beyond ALK-RET, ROS1 and other oncogene fusions in lung cancer.

Shingo Matsumoto, Koichi Goto, Koji Tsuta, 2015, Translational lung cancer research.

Trastuzumab emtansine for patients with non-small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations.

S. Matsumoto, K. Goto, Y. Nakanishi, 2021, European journal of cancer.

In vivo imaging of oxidative stress in the kidney of diabetic mice and its normalization by angiotensin II type 1 receptor blocker.

Shingo Matsumoto, Kunihisa Kobayashi, Toyoshi Inoguchi, 2005, Biochemical and biophysical research communications.

Amplification of EGFR Wild-Type Alleles in Non-Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors.

T. Betsuyaku, S. Matsumoto, S. Mimaki, 2017, Cancer research.

The impact of tertiary lymphoid structures on clinicopathological, genetic and gene expression characteristics in lung adenocarcinoma.

M. Tsuboi, M. Kojima, S. Matsumoto, 2022, Lung cancer.

Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer

S. Matsumoto, K. Yoh, K. Goto, 2020, Journal of Cancer Research and Clinical Oncology.

Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burden.

M. Tsuboi, S. Matsumoto, K. Yoh, 2019, Lung cancer.

Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report

M. Tsuboi, S. Matsumoto, K. Yoh, 2019, Thoracic cancer.

Loss of imprinting of PEG1/MEST in lung cancer cell lines.

Shingo Matsumoto, Eiji Shimizu, Mitsuo Oshimura, 2004, Oncology reports.

Clonal and Parallel Evolution of Primary Lung Cancers and Their Metastases Revealed by Molecular Dissection of Cancer Cells

J. Yokota, T. Kohno, Y. Arai, 2007, Clinical Cancer Research.

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

S. Kobayashi, S. Matsumoto, K. Yoh, 2021, Nature.

Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations

Shingo Matsumoto, Fumie Ono, Koichi Goto, 2019, Proceedings of the National Academy of Sciences.

Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma

Y. Miyagi, Y. Kamatani, Y. Okada, 2016, Nature Communications.

Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women.

X. Hua, Jianxin Shi, Y. Miyagi, 2019, Genomics.

In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization.

James B. Mitchell, H. D. Morris, H. Merkle, 2014, Antioxidants & redox signaling.

An ESR-CT imaging of the head of a living rat receiving an administration of a nitroxide radical.

S. Matsumoto, T. Kitajima, N. Tsuchihashi, 1992, Magnetic resonance imaging.

Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis

Hironobu Ohmatsu, Shingo Matsumoto, Akiko Takahashi, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing

Y. Totoki, T. Kohno, Hiromi Nakamura, 2018, Genome Medicine.

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations

Ping Wang, Junjie Wu, Jian Su, 2016, Human molecular genetics.

Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation

H. Ohmatsu, Y. Ohe, A. Ochiai, 2014, Clinical Cancer Research.

Validity of using immunohistochemistry to predict treatment outcome in patients with non-small cell lung cancer not otherwise specified

S. Matsumoto, K. Yoh, K. Goto, 2019, Journal of Cancer Research and Clinical Oncology.

Imaging cycling tumor hypoxia.

James B. Mitchell, S. Matsumoto, M. Krishna, 2010, Cancer research.

Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma*

H. Esumi, H. Makinoshima, S. Matsumoto, 2014, The Journal of Biological Chemistry.

Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung

M. Tsuboi, H. Ohmatsu, K. Nagai, 2016, Clinical Cancer Research.

Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma

Y. Ohe, A. Ochiai, K. Nagai, 2015, Journal of Cancer Research and Clinical Oncology.

Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma

H. Esumi, A. Ochiai, H. Makinoshima, 2015, The Journal of Biological Chemistry.

Changes in the tumor microenvironment during lymphatic metastasis of lung squamous cell carcinoma

T. Betsuyaku, M. Tsuboi, H. Ohmatsu, 2017, Cancer science.

Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier.

Leah E. Mechanic, Krista A. Zanetti, X. Wang, 2007, Journal of the National Cancer Institute.

Frequent EGFR mutations in noninvasive bronchioloalveolar carcinoma

Kenji Suzuki, J. Yokota, T. Kohno, 2006, International journal of cancer.

Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase-inhibitory fluoropyrimidine in EGFR-mutated lung adenocarcinoma: Retrospective and in vitro studies

E. Shimizu, S. Matsumoto, T. Igishi, 2015, International journal of oncology.

Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma

M. Tsuboi, A. Gemma, H. Ohmatsu, 2016, Journal of Cancer Research and Clinical Oncology.

Identification of Biological Properties of Intralymphatic Tumor Related to the Development of Lymph Node Metastasis in Lung Adenocarcinoma

H. Ohmatsu, Y. Ohe, A. Ochiai, 2013, PloS one.

Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing agents in K-ras mutation-harboring lung adenocarcinoma cells: implication of EGFR tyrosine kinase inhibitors.

E. Shimizu, S. Matsumoto, T. Igishi, 2014, International journal of oncology.

Frequency of Epidermal Growth Factor Receptor Mutation in Smokers with Lung Cancer Without Pulmonary Emphysema.

E. Shimizu, S. Matsumoto, T. Igishi, 2017, Anticancer research.

Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial.

T. Kohno, Y. Ohe, S. Nomura, 2017, The Lancet. Respiratory medicine.

Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma

H. Ohmatsu, Y. Ohe, A. Ochiai, 2013, Journal of Cancer Research and Clinical Oncology.

Emergence and Targeting of Acquired and Hereditary Resistance to Multikinase RET Inhibition in Patients With RET-Altered Cancer

B. Tuch, T. Kohno, J. Blake, 2019, JCO precision oncology.

Response to Crizotinib Re-administration After Progression on Lorlatinib in a Patient With ALK-rearranged Non-small-cell Lung Cancer.

S. Matsumoto, K. Goto, Takaaki Sasaki, 2019, Clinical lung cancer.

Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset

K. Kiura, M. Satouchi, S. Matsumoto, 2017, Japanese journal of clinical oncology.

Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc

James B. Mitchell, W. Linehan, M. Wei, 2019, Scientific Reports.

CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors

M. Tsuboi, A. Ochiai, S. Matsumoto, 2017, Scientific Reports.

Impact of concomitant medication on clinical outcomes in patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors: A retrospective study

S. Matsumoto, K. Yoh, K. Goto, 2021, Thoracic cancer.

Phase 1/2 study of alectinib in RET-rearranged previously-treated non-small cell lung cancer (ALL-RET)

S. Matsumoto, K. Yoh, K. Goto, 2020, Translational lung cancer research.

Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations.

H. Ohmatsu, Y. Ohe, S. Matsumoto, 2016, Clinical lung cancer.

RECIST progression patterns during EGFR tyrosine kinase inhibitor treatment of advanced non-small cell lung cancer patients harboring an EGFR mutation.

H. Ohmatsu, Y. Ohe, S. Matsumoto, 2015, Lung cancer.

A new rapid method for detecting epidermal growth factor receptor mutations in non-small cell lung cancer

M. Nakamoto, E. Shimizu, S. Matsumoto, 2015, Oncology reports.

Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations.

M. Tsuboi, H. Ohmatsu, A. Ochiai, 2016, Lung cancer.

Impact of single nucleotide polymorphisms on severe hepatotoxicity induced by EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutations.

M. Tsuboi, H. Ohmatsu, Y. Ohe, 2015, Lung cancer.

Late recurrence of lung adenocarcinoma harboring EGFR exon 20 insertion (A763_Y764insFQEA) mutation successfully treated with osimertinib.

N. Sugimoto, Y. Kukita, S. Matsumoto, 2021, Cancer genetics.

Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia

H. Ohmatsu, S. Matsumoto, K. Yoh, 2015, Cancer Chemotherapy and Pharmacology.

Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-β through Akt inhibition

E. Shimizu, S. Matsumoto, H. Nakanishi, 2004, Journal of Cancer Research and Clinical Oncology.

Phase II Trial of Weekly Paclitaxel in Previously Untreated Advanced Non-Small-Cell Lung Cancer

E. Shimizu, S. Matsumoto, T. Igishi, 2003, Oncology.

The Re-analysis of LC-SCRUM-Asia Successfully Detected an Overlooked ROS1 Fusion Gene in a Lung Adenocarcinoma Patient and Led to Proper Treatment

Y. Kukita, S. Matsumoto, K. Goto, 2021, Haigan.

Impact of prophylactic cranial irradiation on pattern of brain metastases as a first recurrence site for limited-disease small-cell lung cancer

S. Matsumoto, K. Yoh, K. Goto, 2018, Journal of radiation research.

Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non‐small cell lung cancer who are treated with neoadjuvant therapy: Identification of prognostic microenvironmental factors after chemoradiation

H. Ohmatsu, Y. Ohe, A. Ochiai, 2013, Pathology international.

P89.06 Prospective Concordance Study of a Multi-Gene PCR Assay and NGS for the Detection of Targetable Gene Alterations in Lung Cancer

S. Matsumoto, K. Yoh, K. Goto, 2021 .

Frequent EGFR mutations in brain metastases of lung adenocarcinoma

J. Yokota, T. Kohno, R. Iwakawa, 2006, International journal of cancer.

Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth

A. Gemma, H. Ohmatsu, Y. Ohe, 2015, Oncotarget.

Phase II Study of Weekly Paclitaxel in Patients with Non-Small Cell Lung Cancer Who Have Failed Previous Treatments

E. Shimizu, S. Matsumoto, T. Igishi, 2004, Oncology.

Renal toxicity caused by brand-name versus generic cisplatin: a comparative analysis.

T. Yamanaka, H. Ohmatsu, Y. Ohe, 2013, Japanese journal of clinical oncology.

13C-MR Spectroscopic Imaging with Hyperpolarized [1-13C]pyruvate Detects Early Response to Radiotherapy in SCC Tumors and HT-29 Tumors

James B. Mitchell, H. D. Morris, M. Matsuo, 2015, Clinical Cancer Research.

The 6-minute pegboard and ring test is correlated with upper extremity activity of daily living in chronic obstructive pulmonary disease

E. Shimizu, S. Matsumoto, T. Igishi, 2013, International journal of chronic obstructive pulmonary disease.

Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma

M. Tsuboi, M. Kojima, S. Matsumoto, 2023, Cancer Immunology, Immunotherapy.

Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset

K. Kiura, M. Satouchi, S. Matsumoto, 2018, Japanese journal of clinical oncology.

Phase II study of ceritinib in alectinib‐pretreated patients with anaplastic lymphoma kinase‐rearranged metastatic non‐small‐cell lung cancer in Japan: ASCEND‐9

Young Hak Kim, S. Matsumoto, M. Maemondo, 2018, Cancer science.

Impact of denosumab use on the survival of untreated non-squamous non-small cell lung cancer patients with bone metastases

S. Matsumoto, K. Yoh, K. Goto, 2017, Journal of Cancer Research and Clinical Oncology.

Comparison of sampling methods for next generation sequencing for patients with lung cancer

S. Matsumoto, K. Goto, K. Kunimasa, 2022, Cancer medicine.

Suitability of transbronchial brushing cytology specimens for next‐generation sequencing in peripheral lung cancer

H. Saji, S. Matsumoto, K. Goto, 2020, Cancer science.

P1.18-04 Neoadjuvant Ceritinib for Locally Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: SAKULA Trial

M. Tsuboi, Y. Hosomi, S. Nomura, 2019, Journal of Thoracic Oncology.

Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS1 fusions

S. Toyooka, K. Kiura, M. Tabata, 2018, Cancer science.

Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer with interstitial pneumonia.

H. Ohmatsu, S. Matsumoto, K. Yoh, 2015, Anticancer Research.

Switch maintenance chemotherapy using S-1 with or without bevacizumab in patients with advanced non-small cell lung cancer: a phase II study.

H. Ohmatsu, Y. Ohe, S. Matsumoto, 2017, Lung cancer.

Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer.

Y. Shimada, S. Matsumoto, K. Muro, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Estimation of tumor microvessel density by MRI using a blood pool contrast agent.

James B. Mitchell, S. Matsumoto, M. Krishna, 2009, International journal of oncology.

Large-scale clinico-genomic profile of non-small cell lung cancer with KRAS G12C: Results from LC-SCRUM-Asia study.

S. Nomura, S. Matsumoto, K. Yoh, 2022, Lung cancer.

Antiangiogenic agent sunitinib transiently increases tumor oxygenation and suppresses cycling hypoxia.

Shingo Matsumoto, James B. Mitchell, Murali C Krishna, 2011, Cancer research.

Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI

Shingo Matsumoto, James B. Mitchell, Marcelino Bernardo, 2009, Proceedings of the National Academy of Sciences.

Imaging of Glucose Metabolism by 13 C-MRI Distinguishes Pancreatic Cancer Subtypes 1 in Mice 2 3

Krishna, James B. Mitchell, P. Choyke, 2022 .

A phase II open-label single-arm study of vandetanib in patients with advanced RET-rearranged non-small cell lung cancer (NSCLC): Luret study.

T. Kohno, T. Yamanaka, Y. Ohe, 2016 .

Comprehensive assessment of PD-L1 expression, tumor mutational burden and oncogenic driver alterations in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

S. Matsumoto, K. Yoh, K. Goto, 2021, Lung Cancer.

Magnetic resonance imaging of the tumor microenvironment in radiotherapy: perfusion, hypoxia, and metabolism.

James B. Mitchell, K. Camphausen, M. Matsuo, 2014, Seminars in radiation oncology.

Pulsed Electron Paramagnetic Resonance Imaging: Applications in the Studies of Tumor Physiology.

James B. Mitchell, S. Matsumoto, M. Krishna, 2017, Antioxidants & redox signaling.

Development of fever following first administration of zoledronate as a prognostic factor in advanced non-small cell lung cancer patients with bone metastases

E. Shimizu, S. Matsumoto, T. Igishi, 2017, Molecular and clinical oncology.

Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

L. Kiemeney, Y. Miyagi, B. Qian, 2023, Nature communications.

Therapeutic impact of mutation subtypes and concomitant STK11 mutations in KRAS–mutated non-small cell lung cancer (NSCLC): A result of nationwide genomic screening project (LC-SCRUM-Japan).

S. Miyamoto, S. Matsumoto, K. Yoh, 2020 .

A minimum of 100 tumor cells in a single biopsy sample is required to assess programmed cell death ligand 1 expression in predicting patient response to nivolumab treatment in non-squamous non-small cell lung carcinoma.

Y. Ohe, S. Matsumoto, K. Yoh, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Prognostic impact and gene expression analysis of peri‐tumoral alveolar macrophage in resected lung adenocarcinoma

M. Tsuboi, M. Kojima, S. Matsumoto, 2023, Cancer science.

Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis

S. Matsumoto, K. Goto, I. Okamoto, 2021, Scientific Reports.

Clonality and heterogeneity of pulmonary blastoma from the viewpoint of genetic alterations: a case report.

J. Yokota, T. Kohno, Y. Arai, 2007, Lung cancer.

Magnetic resonance imaging of tumor oxygenation and metabolic profile

Shingo Matsumoto, Masayuki Matsuo, James B. Mitchell, 2013, Acta oncologica.

Electron Paramagnetic Resonance Imaging of Tumor pO2

James B. Mitchell, S. Matsumoto, M. Krishna, 2012, Radiation research.

Macrophage derived TNFα promotes hepatic reprogramming to Warburg-like metabolism

S. Dimauro, O. Gavrilova, S. Matsumoto, 2019, Journal of Molecular Medicine.

Utility of Site-Specific Biopsy for Diagnosis of Desmoplastic Malignant Mesothelioma.

M. Tsuboi, S. Matsumoto, K. Goto, 2018, The Annals of thoracic surgery.

Dexamethasone interferes with trastuzumab-induced cell growth inhibition through restoration of AKT activity in BT-474 breast cancer cells.

E. Shimizu, S. Matsumoto, T. Igishi, 2008, International journal of oncology.

Dynamic monitoring of localized tumor oxygenation changes using RF pulsed electron paramagnetic resonance in conscious mice

Shingo Matsumoto, Hiroshi Hirata, Nallathamby Devasahayam, 2008, Magnetic resonance in medicine.

Clinical application of the AMOY 9-in-1 panel to lung cancer patients.

S. Matsumoto, K. Goto, K. Kunimasa, 2023, Lung cancer.

Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.

E. Shimizu, S. Matsumoto, H. Nakanishi, 2004, International journal of oncology.

Feasibility and utility of transbronchial cryobiopsy in precision medicine for lung cancer: Prospective single‐arm study

S. Nomura, S. Matsumoto, K. Yoh, 2020, Cancer science.

Proteasome Inhibition Overcomes ALK-TKI Resistance in ALK-Rearranged/TP53-Mutant NSCLC via Noxa Expression

Y. Ohe, S. Matsumoto, K. Yoh, 2020, Clinical Cancer Research.

Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung

M. Tsuboi, H. Ohmatsu, Y. Ohe, 2015, Journal of Cancer Research and Clinical Oncology.

Evalution of oxidative stress in diabetic animals by in vivo electron spin resonance measurement--role of protein kinase C.

S. Matsumoto, H. Utsumi, H. Nawata, 2004, Diabetes research and clinical practice.

Transient decrease in tumor oxygenation after intravenous administration of pyruvate

James B. Mitchell, H. D. Morris, J. Ardenkjaer-Larsen, 2012, Magnetic resonance in medicine.

Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma.

M. Tsuboi, H. Esumi, A. Ochiai, 2018, Cancer research.

A case of dramatic reduction in cancer-associated thrombus following initiation of pembrolizumab in patient with a poor performance status and PD-L1+ lung adenocarcinoma harboring CCDC6-RET fusion gene and NF1/TP53 mutations.

K. Kiura, S. Matsumoto, K. Goto, 2021, Lung cancer.

A case of lung abscess successfully treated by transbronchial drainage using a guide sheath

E. Shimizu, S. Matsumoto, T. Igishi, 2017, Respirology case reports.

Advantageous application of a surface coil to EPR irradiation in overhauser‐enhanced MRI

Shingo Matsumoto, Hiroshi Hirata, Hideo Utsumi, 2007, Magnetic resonance in medicine.

Clinical practice guidance for next‐generation sequencing in cancer diagnosis and treatment (Edition 1.0)

Shingo Matsumoto, Daisuke Kotani, Chikashi Ishioka, 2018, Cancer science.

Reconstruction for Time-Domain In Vivo EPR 3D Multigradient Oximetric Imaging—A Parallel Processing Perspective

Shingo Matsumoto, James B. Mitchell, Calvin A. Johnson, 2009, Int. J. Biomed. Imaging.

Thermochromism of the Crystals of 2,3-Di(p-chlorophenylthio)-1,4-Naphthoquinone

S. Matsumoto, Masashi Tanaka, K. Mogi, 1996 .

Optical Properties, Thermochromism and Crystal Structure of Picric Acid-l,5-Diaminonaphthalene Salt

Hiroshi Suzuki, S. Matsumoto, Masashi Tanaka, 1996 .

Thermochromism of the Crystals of 2, 3-Bis(phenylthio)-1, 4-naphthoquinone

S. Matsumoto, Masashi Tanaka, K. Mogi, 1997 .

Differential Immune-Related Microenvironment Determines PD-1/PD-L1 Blockade Efficacy in Advanced Non-Small Cell Lung Cancer Patients.

T. Kohno, Y. Ohe, S. Matsumoto, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Final survival results for the LURET phase II study of vandetanib in previously treated patients with RET-rearranged advanced non-small cell lung cancer.

T. Kohno, S. Nomura, A. Sato, 2021, Lung cancer.

OA07.03 Clinical Outcome of Non-Small Cell Lung Cancer with EGFR/HER2 Exon 20 Insertions Identified in the LC-SCRUM-Japan

M. Satouchi, S. Matsumoto, K. Yoh, 2019, Journal of Thoracic Oncology.

Low-dose irinotecan as a second-line chemotherapy for recurrent small cell lung cancer.

H. Ohmatsu, Y. Ohe, S. Matsumoto, 2014, Japanese journal of clinical oncology.

Quantitative imaging of pO2 in orthotopic murine gliomas: hypoxia correlates with resistance to radiation

James B. Mitchell, K. Camphausen, S. Matsumoto, 2017, Free radical research.

A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing

Shingo Matsumoto, Yutaka Suzuki, Hiromi Nakamura, 2018, Genome Medicine.

Impact of single nucleotide polymorphisms on severe hepatotoxicity induced by EGFR tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring EGFR mutations.

M. Tsuboi, H. Ohmatsu, Y. Ohe, 2015, Lung cancer.

Feasibility study of cancer genome alterations identified by next generation sequencing: ABC study

T. Yamanaka, M. Kojima, S. Matsumoto, 2018, Japanese journal of clinical oncology.

Imaging cycling tumor hypoxia.

James B. Mitchell, S. Matsumoto, M. Krishna, 2010, Cancer research.

A 750-MHz Electronically Tunable Resonator Using Microstrip Line Couplers for Electron Paramagnetic Resonance Imaging of a Mouse Tumor-Bearing Leg

Shingo Matsumoto, Hiroshi Hirata, Tatsuya Amida, 2018, IEEE Transactions on Biomedical Engineering.

The efficacy of immune checkpoint inhibitors and PD-L1 status in patients with advanced non-small cell lung cancer harboring oncogenic driver alterations: Immuno-oncology biomarker study in LC-SCRUM-Japan.

S. Matsumoto, K. Yoh, K. Goto, 2019, Journal of Clinical Oncology.

Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury.

B. Cravatt, S. Matsumoto, P. Pacher, 2011, Free radical biology & medicine.

Influence of proton T1 on oxymetry using Overhauser enhanced magnetic resonance imaging

James B. Mitchell, S. Matsumoto, H. Utsumi, 2005, Magnetic resonance in medicine.

MRI Assessment of Angiogenesis Inhibitor Sunitinib's Influence on Tumor Oxygenation to Identify an Optimal Chemoradiotherapeutic Window

S. Matsumoto, J. Mitchell, M. Krishna, 2009 .

A novel method of preparing the monoform structure of catalytic antibody light chain

S. Matsumoto, Y. Katayama, R. Kato, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Biochemical features and antiviral activity of a monomeric catalytic antibody light‐chain 23D4 against influenza A virus

S. Matsumoto, Y. Katayama, Tatsuhiro Yamamoto, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A large-scale prospective concordance study of plasma- and tissue-based next-generation targeted sequencing for advanced non-small cell lung cancer (LC-SCRUM-Liquid).

S. Matsumoto, K. Yoh, K. Goto, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Genetic profiling-based prognostic prediction of patients with advanced small-cell lung cancer in large scale analysis.

H. Makinoshima, S. Matsumoto, S. Mimaki, 2018, Lung cancer.

Reporting of quantitative oxygen mapping in EPR imaging.

James B. Mitchell, A. McMillan, S. Matsumoto, 2012, Journal of magnetic resonance.

Biochemical Features of a Catalytic Antibody Light Chain, 22F6, Prepared from Human Lymphocytes

S. Matsumoto, N. Kobayashi, Naoko Fujimoto, 2013, The Journal of Biological Chemistry.

A composite resonator assembly suitable for EPR/NMR coregistration imaging

Mitsuhiro Ono, Shingo Matsumoto, Hiroshi Hirata, 2005 .

Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations.

H. Ohmatsu, Y. Ohe, S. Matsumoto, 2016, Clinical lung cancer.

EPR oxygen imaging and hyperpolarized 13C MRI of pyruvate metabolism as noninvasive biomarkers of tumor treatment response to a glycolysis inhibitor 3‐bromopyruvate

James B. Mitchell, H. Merkle, A. Koretsky, 2013, Magnetic resonance in medicine.